Association for Molecular Pathology

We provide global expertise in molecular testing that drives patient care.

[The Journal of Molecular Diagnostics @JMDiagn]

#LegacyContent: Clinical Implementation of Matched Tumor/Germline Sequencing Improves Accuracy of Tumor Genomic Profiling and Therapeutic Recommendations. Authors from @BrighamWomens, @DanaFarber and @BostonChildrens.

Free in the #OpenArchive: https://t.co/4sepT8gxBH

[Association for Molecular Pathology @AMPath]

🎤 Calling all AMP trainees with talent! Perform in the #AMP2026 talent show and receive a complimentary ticket to the Amazing Molecular Party on Nov. 13!

Email [email protected] by Oct. 30 with your proposed act (five minutes maximum).

[Association for Molecular Pathology @AMPath]

Join us Oct. 29 at 1 p.m. Eastern for a free webinar exploring ctDNA-based MRD detection and its potential applications in risk stratification, surveillance and treatment selection.

https://t.co/Mjd1l0HaLx

[Covaris @Covaris]

Heading to #AMP2026? Visit Covaris at Booth #2409!
Join our Corporate Workshop with Quest Diagnostics on FFPE tissue stewardship and our Innovation Spotlight featuring experts from UCSF and Covaris.
Learn more and register: https://t.co/1iTTIctkRa

[countablelabs @countablelabs]

Meet Countable Labs at #AMP2026! 🔬

Discover single-molecule #PCR for BCR::ABL1, KMT2A, NPM1 & methylation at Booth #943.

📊 4 posters
🤝 Live demos
🎤 Workshop with @fredhutch, @UTMDAnderson & HematoLogics

Learn more: https://t.co/JDQpn9aJtM

@AMPath

[American Clinical Laboratory Association @ACLAlabs]

Thank you to the organizations who joined ACLA on Capitol Hill today! Together, we met with congressional offices to urge passage of the #RESULTSAct and protect patient access to essential testing. #StopLabCuts. https://t.co/sS7bGqjlbv

[Ting Zhao, MD @TingZhaoPathdoc]

Heading to #AMP2026? Don’t miss the plenary presentations and awards ceremony!
@AMPath #MolPath #PrecisionMedicine

[Association for Molecular Pathology @AMPath]

In leukemia testing, molecular labs face a difficult trade-off: broad detection of fusions and mutations or the deep sensitivity required for MRD. Watch this OCW to explore how @countablelabs' single-molecule counting assays are designed to address both.

https://t.co/nCCQlWcEb3

[Association for Molecular Pathology @AMPath]

New AMP case report in CAP Today: "Comprehensive Molecular Characterization of an Aggressive Infant-Type Hemispheric Glioma with a Novel PRKAR2A::ALK Fusion" 👉 https://t.co/9LG0tdjYqI

[Association for Molecular Pathology @AMPath]

🗓️ Today’s the last day to register for #AMP2026 at the standard registration rate. Register by 11:59 p.m. Eastern to save.

Don’t wait until it’s too late!

Register: https://t.co/WEMBt9mIFE

[Association for Molecular Pathology @AMPath]

Today: Join us along with @ToniSepulvedaMD for a free webinar on alternative workflows for ordering biomarker and NGS tumor testing in colorectal and other gastrointestinal cancers covering multiple models and evaluate how these approaches affect outcomes.
https://t.co/QZrFpfVgwN

[Association for Molecular Pathology @AMPath]

📅 Oct. 28 | 🕒 1 p.m. Eastern ➡️A practical path to NGS: Clonality and ultra-high sensitivity MRD assessment in lymphoid malignancies (hosted by Invivoscribe)

Register for free: https://t.co/Wf0jtAqPvt

[Association for Molecular Pathology @AMPath]

🧛 Transform hematologic diagnostics with your molecular insights.

@JMDiagn invites papers on NGS panels, fusion detection, MRD and molecular testing in leukemias, lymphomas and related disorders.

Submit here: https://t.co/PLTbZGB0Au

[Association for Molecular Pathology @AMPath]

Advocacy update: In a letter, 19 members of Congress have urged CMS not to make unilateral changes to surgical pathology service valuations in the 2027 Medicare Physician Fee Schedule.

Read the letter: https://t.co/IjwQMfggJX

[Association for Molecular Pathology @AMPath]

➡️ Sunday: Last day to book your #AMP 2026 room with our discount.

Hotel information: https://t.co/HCdnp0lbA6

➡️ Tuesday: Last day for regular registration. After that, the (higher) on-site rate applies.

Register: https://t.co/L8Bh3o92hj

[Association for Molecular Pathology @AMPath]

FREE webinar ➡️A practical path to NGS: Clonality and ultra-high sensitivity MRD assessment in lymphoid malignancies

📅 Oct. 28 | 🕒 1 p.m. Eastern

https://t.co/Wf0jtAqPvt

[Association for Molecular Pathology @AMPath]

How can circulating tumor DNA (ctDNA) help detect minimal residual disease (MRD) in solid tumors?
Join us Oct. 29 for a free webinar covering ctDNA-based MRD detection, emerging clinical applications and challenges in translating these tests into practice

https://t.co/Mjd1l0HaLx

[Association for Molecular Pathology @AMPath]

TODAY is the final broadcast in our Body of Knowledge series, based on the @JMDiagn papers. Join us at 1 p.m. ET to discuss:

✅Regulatory & standards organizations
✅U.S. lab regulations impacting clinical bioinformaticians
✅Data security best practices

https://t.co/UhWXqVEZ0R

[Association for Molecular Pathology @AMPath]

Engage with our advocacy experts and other professionals working to address critical challenges in the field of molecular pathology by joining us at #AMP2026 in Seattle, Nov. 10–14.

Be a part of the change you want to see. Register: https://t.co/yGUinuEEKg

[Association for Molecular Pathology @AMPath]

Join us Oct. 20 for a free webinar with @ToniSepulvedaMD exploring alternative workflows for biomarker and NGS tumor testing in colorectal and other GI cancers and their impact on efficiency, turnaround time, access to results and patient care.

Register: https://t.co/QZrFpfVgwN